在早期发病的帕金森病中存在线粒基因基因变化
Rana Abu Manneh1,2, Paraskevi P Chairta1, Maria A Loizidou2
1Neuroepidemiology Department, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus.
International journal of molecular sciences
|February 27, 2026
概括
线粒体DNA (mtDNA) 的甲基化模式在早期发病的帕金森病 (EOPD) 中不同. 这些表观遗传变化,包括整个mtDNA的甲基化和基甲基化,显示出潜在的基于血液的生物标志物用于EOPD诊断.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
背景情况:
- 显著的线粒体DNA (mtDNA) 甲基化和基甲基化模式越来越多地与帕金森病 (PD) 相关.
- 以前的研究集中在特定的mtDNA区域,缺乏非CpG上下文分析,并面临方法上的局限性.
- 在早期发病的PD (EOPD) 中,需要对整个线粒体基因组的表观遗传景观进行全面分析.
研究的目的:
- 在整个线粒体基因组中全面描述全球和单基因分辨率甲基化和基甲基化.
- 为了研究这些表观遗传修饰在CpG和非CpG背景中的血液样本从EOPD患者和对照.
- 评估mtDNA (基) 甲基化模式作为EOPD的基于血液的生物标志物的潜力.
主要方法:
- 分析了39名EOPD患者和63名年龄和性别匹配的对照组的血液样本.
- 使用双硫酸盐 (BS) 和氧化双硫酸盐 (oxBS) 转换,然后采用下一代测序 (NGS) 的并行工作流.
- 在CpG,CHG和CHH上下文中确定了线粒体5-甲基细胞氨酸 (5mC) 和5-基甲基细胞氨酸 (5hmC).
主要成果:
- 全球mtDNA甲基化在EOPD患者中明显高于BS和oxBS状态的对照组 (真甲基化).
- 在单基分辨率下进行的分析显示,在EOPD患者中,D环区域和CpG环境中主要存在低甲基化位点.
- 在EOPD中,在所有情境 (CpG,CHG,CHH) 中都观察到甲基化和基甲基化的显著差异.
结论:
- 综合分析显示,在EOPD.中,全球和特定地点mtDNA (基) 甲基化发生了显著的变化.
- 在CpG和非CpG环境中识别的表观遗传模式为PD病变发生提供了新的见解.
- 全球和基本分辨率mtDNA (基) 甲基化档案都显示出早期发病帕金森病的可靠血液生物标志物的潜力.
更多相关视频
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
10.5K
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
2.3K
相关概念视频
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Neural Regulation
43.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.8K
Epigenetic Regulation
4.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
4.0K
